LYEL

#3109
Lyell Immunopharma, Inc. - Common Stock
17.3 1 USD
+10185.20%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
17.31
17.48
Year Range
15.49
27.75
Daily Change
+10185.20%
Monthly Change
-16.13%
6 month change
-28.44%
Year Change
-28.44%
Previous Close
0.1 7
Open
17.3 9
Low
17.3 1
High
17.4 8
Volume
19
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 403.91 M
  • Employee 161
  • Founded 2018
  • CEO N/A
  • Website www.lyell.com
  • Headquarter Delaware, United States
  • FIGI BBG00RNXFN14
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.47
Price to sales ratio
11.12 K

News